|
|
|
| |
|
| |
 |
| |
Gynazole•1® for the treatment of vulvo-vaginal yeast infections contains butoconazole nitrate (2%) as active principle. Thanks to its high bioadhesiveness to the vaginal cell wall, Gynazole•1® brings rapid relief of symptoms of vulvovaginal mycoses in less than 4 hours. A unique pre-filled device allows the application of a single dose at any time of the day or night.
For detailed information, please visit www.gynazole-1.com |
|
|
|
|